NO20071165L - Midler for a forbedre konstitusjonell funksjon - Google Patents

Midler for a forbedre konstitusjonell funksjon

Info

Publication number
NO20071165L
NO20071165L NO20071165A NO20071165A NO20071165L NO 20071165 L NO20071165 L NO 20071165L NO 20071165 A NO20071165 A NO 20071165A NO 20071165 A NO20071165 A NO 20071165A NO 20071165 L NO20071165 L NO 20071165L
Authority
NO
Norway
Prior art keywords
function
improving
improve
constitutional
constitutional function
Prior art date
Application number
NO20071165A
Other languages
English (en)
Other versions
NO336392B1 (no
Inventor
Tohru Tanaka
Masao Kondo
Naomi Aiba
Setsuko Miyanari
Takaya Suzuki
Masahiro Ishizuka
Original Assignee
Cosmo Oil Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2004255576A external-priority patent/JP4814501B2/ja
Priority claimed from JP2005218436A external-priority patent/JP4814568B2/ja
Priority claimed from JP2005218435A external-priority patent/JP4814567B2/ja
Application filed by Cosmo Oil Co Ltd filed Critical Cosmo Oil Co Ltd
Publication of NO20071165L publication Critical patent/NO20071165L/no
Publication of NO336392B1 publication Critical patent/NO336392B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Konstitusjonelle funksjonsforbedrende midler slik som et middel for å forbedre immunfunksjon, et middel for å forbedre antioksidativ funksjon, et middel for å forbedre bevelighetsfunksjon og et middel for å forbedre leverfunksjon, som hver inneholder en d-aminosyre, dens derivat eller dens salt som den aktive bestanddel.
NO20071165A 2004-09-02 2007-03-01 Middel for å forbedre immunologisk funksjon NO336392B1 (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2004255575 2004-09-02
JP2004255576A JP4814501B2 (ja) 2004-09-02 2004-09-02 抗酸化機能向上剤
JP2004255577 2004-09-02
JP2005218436A JP4814568B2 (ja) 2004-09-02 2005-07-28 免疫機能向上剤
JP2005218435A JP4814567B2 (ja) 2004-09-02 2005-07-28 健康機能向上剤
PCT/JP2005/015560 WO2006025286A1 (ja) 2004-09-02 2005-08-26 健康機能向上剤

Publications (2)

Publication Number Publication Date
NO20071165L true NO20071165L (no) 2007-06-04
NO336392B1 NO336392B1 (no) 2015-08-10

Family

ID=35999940

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071165A NO336392B1 (no) 2004-09-02 2007-03-01 Middel for å forbedre immunologisk funksjon

Country Status (9)

Country Link
US (1) US8790712B2 (no)
EP (2) EP2727589B1 (no)
KR (2) KR100966318B1 (no)
CN (2) CN101010076B (no)
AU (1) AU2005278649B8 (no)
CA (2) CA2752569C (no)
ES (1) ES2459366T3 (no)
NO (1) NO336392B1 (no)
WO (1) WO2006025286A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10426792B1 (en) * 2007-09-18 2019-10-01 Thermolife International, Llc Amino acid compositions
US10426750B1 (en) 2007-09-18 2019-10-01 Thermolife International, Llc Amino acid supplement formulations
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US10435356B1 (en) * 2007-09-18 2019-10-08 Thermolife International, Llc Amino acid compositions
US10646508B1 (en) * 2007-09-18 2020-05-12 Thermolife International, Llc Method of safely administering nitrate dietary supplements and compositions
US8563605B2 (en) 2008-05-14 2013-10-22 Sbi Pharmaceuticals Co., Ltd. Therapeutic agent for male sterility
KR101322259B1 (ko) 2008-10-27 2013-10-28 에스비아이 파마 가부시키가이샤 5-아미노레불린산 혹은 그의 유도체, 또는 그들 염을 유효성분으로 하는 성인병의 예방·개선제
JP5611548B2 (ja) * 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
PL2696865T3 (pl) 2011-04-13 2017-07-31 Thermolife International, Llc Sposoby zastosowania N-acetylo beta-alaniny
JP5713473B2 (ja) * 2011-06-16 2015-05-07 Ｓｂｉファーマ株式会社 アレルギー性鼻炎の治療剤
JP6052736B2 (ja) * 2011-08-12 2016-12-27 Ｓｂｉファーマ株式会社 敗血症の予防剤及び／又は治療剤
JP5881721B2 (ja) 2011-10-12 2016-03-09 Ｓｂｉファーマ株式会社 慢性腎臓病の改善・予防剤
CN106110326A (zh) * 2011-10-12 2016-11-16 思佰益药业股份有限公司 移植器官的成活促进剂
EP2767277B1 (en) 2011-10-12 2018-11-28 SBI Pharmaceuticals Co., Ltd. Treatment agent and/or prophylactic agent for side effects of cancer drugs
JP5818905B2 (ja) 2011-10-12 2015-11-18 Ｓｂｉファーマ株式会社 エリスロポエチン産生促進剤
TWI571455B (zh) 2011-12-07 2017-02-21 Sbi Pharmaceuticals Co Ltd To prevent alcohol from causing discomfort to the human body of the hangover preventive agent and / or therapeutic agent
WO2014010206A1 (ja) 2012-07-13 2014-01-16 Ｓｂｉファーマ株式会社 免疫寛容誘導剤
JP5920901B2 (ja) * 2012-07-19 2016-05-18 Ｓｂｉファーマ株式会社 インフルエンザウイルス感染症の予防・治療剤
EP3168296B1 (en) * 2014-07-11 2020-09-09 SBI Pharmaceuticals Co., Ltd. Agent for improving normal development rate of fertilized eggs
CN104146142A (zh) * 2014-07-28 2014-11-19 四川安益生物科技有限公司 一种复合保健食品及其制备方法
JP2020130001A (ja) * 2019-02-15 2020-08-31 ネオファーマジャパン株式会社 泌乳牛の乳におけるタンパク質含量増加剤
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
JP2024541338A (ja) 2020-11-12 2024-11-08 サーモライフ インターナショナル， エルエルシー 血中酸素飽和度を増大させる方法
EP4291206A4 (en) 2021-02-11 2025-01-08 Thermolife International, LLC A method of administering nitric oxide gas
KR102974010B1 (ko) * 2022-11-25 2026-06-05 진안당 영농조합법인 식물 혼합 추출물 및 해양성 부식토 추출물의 복합물을 유효성분으로 함유하는 면역증진용 조성물 및 이의 제조방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1068478A (en) * 1963-07-30 1967-05-10 Kyowa Hakko Kogyo Kk Increasing amino-acid content of food
JPS4892328A (no) 1972-03-17 1973-11-30
JPS62111954A (ja) 1985-11-09 1987-05-22 Japan Spectroscopic Co アミノレブリン酸の合成法
JPH0276841A (ja) 1988-09-09 1990-03-16 Osaka Organic Chem Ind Ltd アミノレブリン酸類の製造法
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
JPH05117110A (ja) 1991-10-23 1993-05-14 Cosmo Sogo Kenkyusho:Kk 除草剤及び除草方法
DE4228084C1 (de) 1992-08-24 1993-12-23 Suedzucker Ag Verfahren zur Herstellung von N-Acylderivaten der 5-Aminolävulinsäure sowie des Hydrochlorids der freien Säure
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
JP2747644B2 (ja) 1993-08-19 1998-05-06 株式会社コスモ総合研究所 植物成長調節剤
DE4341000A1 (de) 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
DE4341001A1 (de) 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
JPH07188133A (ja) 1993-12-27 1995-07-25 Asahi Chem Ind Co Ltd δ−アミノレブリン酸またはその同族体の製造法
JP3814683B2 (ja) 1996-01-09 2006-08-30 独立行政法人理化学研究所 アミノ酸組成物
JPH10139678A (ja) 1996-11-14 1998-05-26 Taisho Pharmaceut Co Ltd 生体内抗酸化剤
JPH10215811A (ja) * 1997-02-07 1998-08-18 Meiji Seika Kaisha Ltd 脂肪の燃焼を促進させる飲食品
WO1998036730A2 (de) 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die behandlung von rosacea
JP3026190B2 (ja) 1997-05-27 2000-03-27 株式会社コスモ総合研究所 ５−アミノレブリン酸生産微生物及びこれを用いた５−アミノレブリン酸の製造法
JP4038280B2 (ja) 1998-09-14 2008-01-23 シスメックス株式会社 無侵襲生体成分計測装置
WO2000043199A1 (en) * 1999-01-20 2000-07-27 Reference Diagnostics, Inc. Magnetically responsive gel particle
NZ527924A (en) 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
KR100365151B1 (ko) 2000-05-08 2003-02-11 김형락 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도
JP3827923B2 (ja) 2000-06-20 2006-09-27 味の素株式会社 造血および栄養状態改善用アミノ酸組成物
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
DE10063076A1 (de) * 2000-12-18 2002-06-27 Medac Klinische Spezialpraep Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe
JP4754731B2 (ja) * 2001-07-31 2011-08-24 コスモ石油株式会社 豚成育促進剤及び豚成育促進方法
JP2003277284A (ja) * 2002-03-25 2003-10-02 Eisai Co Ltd 抗酸化力増強剤
JP4345311B2 (ja) * 2003-01-22 2009-10-14 東亞合成株式会社 抗酸化剤
KR100459918B1 (ko) * 2002-06-19 2004-12-03 (주)엔바이로젠 델타아미노레불린산을 함유하는 생육촉진용 가축사료 첨가제

Also Published As

Publication number Publication date
US20080026075A1 (en) 2008-01-31
WO2006025286A1 (ja) 2006-03-09
EP2727589B1 (en) 2018-11-28
EP1785132A4 (en) 2013-02-13
CN101010076B (zh) 2010-06-09
KR100966318B1 (ko) 2010-06-28
ES2459366T3 (es) 2014-05-09
AU2005278649A1 (en) 2006-03-09
AU2005278649B2 (en) 2010-07-01
CN101822661A (zh) 2010-09-08
KR20070058583A (ko) 2007-06-08
AU2005278649B8 (en) 2010-07-22
EP1785132A1 (en) 2007-05-16
US8790712B2 (en) 2014-07-29
NO336392B1 (no) 2015-08-10
CN101010076A (zh) 2007-08-01
EP1785132B1 (en) 2014-04-09
EP2727589A1 (en) 2014-05-07
CA2752569A1 (en) 2006-03-09
KR20100016341A (ko) 2010-02-12
CA2752569C (en) 2014-09-16
CA2579032A1 (en) 2006-03-09
CA2579032C (en) 2011-11-29

Similar Documents

Publication Publication Date Title
ES2606342T3 (es) Composiciones para el cuidado bucal de sal estannosa y tripoli-fosfato de sodio y métodos
JP2009531457A5 (no)
NO20091395L (no) Nye tiofenderivater
NO20074238L (no) Fiksert dosering av HER-antistoffer
MX393384B (es) Adyuvantes sinteticos de glucopiranosil-lipido.
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
EA201170703A1 (ru) Производные адамантилбензамида
ECSP088214A (es) Formulaciones de acetato de bazedoxifeno que tienen una conversión polimórfica reducida
NO20092611L (no) Krystallinsk faststoff Rasagilin base
BRPI0610108B8 (pt) compostos promotores de apoptose e composição que compreende os ditos compostos
NO20082793L (no) Nye tiofenderivater
CL2012003226A1 (es) Compuestos derivados de 5-fluoro-1h-pirazolopiridina ; procedimiento de preparacion de estos; composicion framaceutica que los comprende; y su uso en el tratamiento de enfermedades cardiovasculares, sexuales y metabolicas.
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
NO20084821L (no) Formuleringer og metoder for celleimaging og terapi
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
HRP20201242T1 (hr) Tekući farmaceutski pripravak
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
NO20063393L (no) Farmasoytiske preparater
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SBI PHARMACEUTICAL CO LTD, JP

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SBI PHARMACEUTICAL CO LTD, JP